• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Enveric Biosciences, Inc. (ENVB) Stock Price, News & Analysis

Enveric Biosciences, Inc. (ENVB) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.34

-$0.01

(-3.72%)

Day's range
$0.31
Day's range
$0.34
50-day range
$0.3051
Day's range
$0.555
  • Country: US
  • ISIN: US29405E2081
52 wk range
$0.31
Day's range
$2.92
  • CEO: Dr. Joseph Edward Tucker Ph.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -34.07
  • Piotroski Score 3.00
  • Grade Buy
  • Symbol (ENVB)
  • Company Enveric Biosciences, Inc.
  • Price $0.34
  • Changes Percentage (-3.72%)
  • Change -$0.01
  • Day Low $0.31
  • Day High $0.34
  • Year High $2.92

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

  • Last Earnings 04/07/2008
  • Ex-Dividend for 5/16 Dividend 04/23/2008
  • Dividend Payable N/A
  • Today N/A
  • Next Earnings (Estimated) 03/24/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$6.39
  • Trailing P/E Ratio -0.12
  • Forward P/E Ratio -0.12
  • P/E Growth -0.12
  • Net Income $-17,292

Income Statement

Quarterly

Annual

Latest News of ENVB

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Enveric Biosciences, Inc. Frequently Asked Questions

  • What were the earnings of ENVB in the last quarter?

    In the last quarter Enveric Biosciences, Inc. earnings were on Monday, August, 12th. The Enveric Biosciences, Inc. maker reported -$0.25 EPS for the quarter, beating analysts' consensus estimates of -$0.55 by $0.30.

  • What is the Enveric Biosciences, Inc. stock price today?

    Today's price of Enveric Biosciences, Inc. is $0.34 — it has decreased by -3.72% in the past 24 hours. Watch Enveric Biosciences, Inc. stock price performance more closely on the chart.

  • Does Enveric Biosciences, Inc. release reports?

    Yes, you can track Enveric Biosciences, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Enveric Biosciences, Inc. stock forecast?

    Watch the Enveric Biosciences, Inc. chart and read a more detailed Enveric Biosciences, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Enveric Biosciences, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Enveric Biosciences, Inc. stock ticker.

  • How to buy Enveric Biosciences, Inc. stocks?

    Like other stocks, ENVB shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Enveric Biosciences, Inc.'s EBITDA?

    Enveric Biosciences, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Enveric Biosciences, Inc.’s financial statements.

  • What is the Enveric Biosciences, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Enveric Biosciences, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Enveric Biosciences, Inc.'s financials relevant news, and technical analysis. Enveric Biosciences, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Enveric Biosciences, Inc. stock currently indicates a “sell” signal. For more insights, review Enveric Biosciences, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.